Disclaimer

We’re actively expanding Guideline Genius to cover the full UKMLA content map. Therefore, you may notice some conditions not uploaded yet, or articles that currently focus on diagnosis and management for now.

We are also continuously reviewing and updating existing content to ensure accuracy and alignment with current guidelines. Some earlier articles are undergoing revision as part of this process. Once all content has been fully reviewed, this will be clearly communicated on the platform.

For updates, follow us on Instagram @guidelinegenius.

We welcome any feedback or suggestions via the anonymous feedback box at the bottom of each article and will do our best to respond promptly.

Thank you for your support.
The Guideline Genius Team

Total Live Articles: 372

Postpartum Haemorrhage (PPH)

RCOG Prevention and Management of Postpartum Haemorrhage (Green-top Guideline No. 52). Last reviewed: Dec 2016.

Definition

There are 2 types of PPH:

  • Primary PPH: loss of ≥500 mL of blood from the genital tract, within 24 hours of the birth of a baby
  • Secondary PPH: abnormal or excessive bleeding from the birth canal between 24 hours and 12 weeks postnatally

PPH can be classified by blood loss volume:

  • Minor PPH: blood loss of 500-1000 mL
  • Major PPH: blood loss of >1000 mL

Aetiology

Primary PPH

The causes of PPH can be grouped into four mechanisms, collectively known as the ‘4 Ts’:

Mechanism Specific cause Key risk factors / associations
Tone (uterine atony) ~70% Uterine overdistension
  • Multiple pregnancy
  • Polyhydramnios
  • Fetal macrosomia
Impaired uterine contraction
  • Prolonged labour / rapid labour
  • Uterine anomalies (e.g. fibroids, placenta praevia)
  • Chorioamnionitis
  • Use of uterine relaxants (e.g. magnesium, nifedipine, terbutaline, halogenated anaesthetics, GTN)
Trauma ~20% Genital tract / uterine injury
  • Perineal / vaginal / cervical lacerations
  • Episiotomy
  • Instrumental vaginal delivery
  • Uterine rupture
Tissue ~10% Retained placenta / products
  • Placenta accreta spectrum
  • Retained placenta
  • Retained products of conception
Thrombin <1% Coagulopathy
  • Pre-existing coagulopathy (e.g. haemophilia, von Willebrand disease)
  • Coagulopathy acquired in pregnancy (e.g. gestational thrombocytopaenia, HELLP syndrome)
  • DIC
  • Dilutional coagulopathy (secondary to massive transfusion)

The most common identifiable cause of PPH is uterine atony (tone).

Most cases of PPH actually occur in women with no identifiable risk factors.

Secondary PPH

Key causes include:

  • Endometritis
  • Retained products of conception
  • Subinvolution of placental implantation site

Work-Up

Primary PPH

Investigations in PPH are not cause-specific. Their primary purpose is to assess the severity of haemorrhage, guide resuscitation, and monitor end-organ function.

  • Minor PPH (500-1000 mL): FBC, group and save, coagulation screen
  • Major PPH (>1000 mL):
    • FBC, group and save, coagulation screen
    • Cross-match at least 4 units of blood
    • U&E, LFTs
    • Continuous physiological monitoring (e.g. pulse, BP, RR)
    • Catheterisation to monitor urine output

The cause of PPH is almost always identified clinically

  • Uterine atony → soft, boggy uterus which may be larger than expected (distended with clot)
  • Trauma → direct visualisation on inspection and/or speculum
  • Tissue
    • Placenta fails to deliver / separate → placenta accreata spectrum
    • Ultrasound with echogenic material within the uterine cavity → retained production of conception
  • Thrombin → laboratory confirmation

Secondary PPH

The following investigations are recommended:

  • High vaginal and endocervical swabs – to test for endometritis
  • Pelvic ultrasound – to identify or exclude retained products of conception

Suspect endometritis in those with:

  • Secondary PPH (bleeding between 24 hours and 12 weeks postnatally)
  • Fever
  • Foul-smelling lochia
  • Uterine tenderness
  • Abdominal pain and/or pelvic pain

Prevention

Preventive strategies are aimed at preventing primary PPH.

Strategies to be offered to ALL women:

  • Identify and treat any antenatal anaemia (see the Anaemia in Pregnancy article for more information)
  • Offer routine prophylactic uterotonic drugs (usually oxytocin) during 3rd stage of labour

Strategies specific to those at risk of primary PPH:

  • Deliver in a hospital with a blood bank on site
  • Consider giving tranexamic acid to those who are delivered by Caesarean section

DO NOT offer the following to prevent primary PPH:

  • Routine uterine massage 
  • Early cord clamping

Management

Primary PPH

Routine / Non-Specific Management

Regardless of the underlying cause, the initial focus is always on resuscitation

  • Call for help + A-E approach
  • Fluid resuscitation and/or RBC transfusion (therapeutic goal is to maintain Hb >80 g/L)
  • Consider tranexamic acid to reduce bleeding and the need for transfusions

Atony-Specific Management

As the most common cause of primary PPH (~70% of cases), the management protocol for uterine atony is strongly emphasised and is high-yield for exams.

The following applies when uterine atony is suspected to cause PPH. Measures should be escalated sequentially until the bleeding stops.

Step Measure type Recommended management
1 Mechanical
  • Fundal rub – palpate the uterine fundus and physically rub it to stimulate myometrial contractions
  • Insert a catheter to empty the bladder (as a distended bladder can prevent uterine contraction)
2 Pharmacological If mechanical measures fail, administer the following drugs in sequence until the bleeding stops:
  1. Oxytocin slow IV injections
  2. Ergometrine IV / IM (NB contraindicated in hypertension)
  3. Oxytocin infusion
  4. Carboprost IM injection
  5. Misoprostol sublingually
3 Surgical and radiological If pharmacological measures fail, attempt and escalate the following in sequence until the bleeding stops:
  1. Intrauterine balloon tamponade (e.g. Bakri or Rusch balloon)
  2. Haemostatic suturing (e.g. B-Lynch or Hayman techniques)
  3. Interventional radiological interventions
  4. Last resort and definitive management: hysterectomy (subtotal hysterectomy is generally preferred)

Other Cause-Specific Management

Overview of management directed towards the underlying cause:

Underlying cause Management principle
Placenta accreta spectrum Hysterectomy
Uterine rupture Hysterectomy
Coagulopathies Depends on the coagulation profile
  • Thrombocytopaenia (platelet count <75 x 109/L) → platelet transfusion
  • Prolonged PT / APT (>1.5x normal) → FFP transfusion
  • Hypofibrinogenaemia (<2 g/L) → cryoprecipitate transfusion

Secondary PPH

Initial management: resuscitation if necessary

Definitive management depends on the underlying cause:

Underlying cause Management
Endometritis Clindamycin + gentamicin
Retained placental tissue Surgical evacuation

Reference

Share Your Feedback Below

UK medical guidelines made easy. From guidelines to genius in minutes!

Quick Links

Cookie Policy

Social Media

© 2026 GUIDELINE GENIUS LTD

Be first to accessour QBank

Sign up to receive major guideline updates and early access when we launch.